AMIT KUMAR
CIK 1191905 · Chief Executive Officer · last filed 2026-08-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.83M
Companies
7
Total Filings
152
Lifetime Open-Market Net
$1.35M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIX | Chief Executive Officer | 657,000 | $3.49 | $2.29M | $943.6K | 39 | 2026-08-03 |
| Anixa Biosciences Inc (ITUS) Delisted | Chief Executive Officer | 139,000 | — | — | $140.9K | 15 | 2018-09-18 |
| ASTI | Director | 0 | $3.27 | $0 | $0 | 9 | 2016-05-23 |
| CombiMatrix Corp (CBMX) Delisted | President and CEO | 629 | — | — | $266.1K | 32 | 2012-01-05 |
| Ascent Solar Technologies, Inc. (ASTIZ) Delisted | Director | 45,207 | — | — | -$6.7K | 15 | 2011-06-22 |
| CombiMatrix Corp (CBMXD) Delisted | President & CEO | 198,444 | — | — | $6.2K | 2 | 2007-09-07 |
| ACTG | Pres/CEO of CombiMatrix Corp. | 328,614 | $4.68 | $1.54M | $0 | 1 | 2007-05-08 |
Recent Filings · Page 5 of 16
152 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-09-14 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +3,000 | $11.5K | EDGAR |
| 2018-09-13 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +4,112 | $16.3K | EDGAR |
| 2018-09-12 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +4,480 | $17.9K | EDGAR |
| 2018-05-14 | Anixa Biosciences Inc (ITUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-08 | Anixa Biosciences Inc (ITUS) Delisted | Mixed | — | $0 | EDGAR |
| 2017-06-06 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +10,000 | $9.0K | EDGAR |
| 2017-06-05 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +10,000 | $8.8K | EDGAR |
| 2016-05-23 | ASTI | Grant (A) | +566,664 | $0 | EDGAR |
| 2016-03-02 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +2,000 | $4.9K | EDGAR |
| 2016-02-19 | Anixa Biosciences Inc (ITUS) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.